Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Lifshitz Law Firm Announces Investigation of Caribou Coffee Company, Inc., Epoch Holding Corporation, Somaxon Pharmaceuticals,



  Lifshitz Law Firm Announces Investigation of Caribou Coffee Company, Inc.,
      Epoch Holding Corporation, Somaxon Pharmaceuticals, Inc. and Young
                              Innovations, Inc.

PR Newswire

NEW YORK, Dec. 17, 2012

NEW YORK, Dec. 17, 2012 /PRNewswire/ --

Caribou Coffee Company, Inc.

Lifshitz Law Firm announces an investigation into possible breaches of
fiduciary duty in connection with the proposed sale of Caribou Coffee Company,
Inc. (Nasdaq: CBOU) to Joh. A. Benckiser Group for $16.00 per share in cash,
or a total of approximately $340 million. 

For more information about our investigation, please contact Joshua M.
Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail
including your contact information to: info@jlclasslaw.com.

Epoch Holding Corporation

Lifshitz Law Firm announces an investigation into possible breaches of
fiduciary duty in connection with the proposed sale of Epoch Holding
Corporation (Nasdaq: EPHC) (referred to as "Epoch") to TD Bank Group for cash
consideration of approximately $668 million.  Pursuant to the merger
agreement, each Epoch stockholders will receive $28.00 in cash per share.

For more information about our investigation, please contact Joshua M.
Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail
including your contact information to: info@jlclasslaw.com.

Somaxon Pharmaceuticals, Inc.

Lifshitz Law Firm announces an investigation into possible breaches of
fiduciary duty in connection with the proposed sale of Somaxon
Pharmaceuticals, Inc. (Nasdaq: SOMX) (referred to as "Somaxon") to Pernix
Therapeutics Holdings, Inc. (referred to as "Pernix").  Under the terms of the
agreement, Somaxon stockholders will receive aggregate consideration equal to
$25 million in Pernix common stock.  The number of shares of Pernix common
stock to be issued to the stockholders of Somaxon will be based on the
volume-weighted average price of Pernix's common stock over the 30 day period
ending on the day immediately prior to the closing of the proposed merger,
subject to limitations on the maximum and minimum number of shares of Pernix
common stock issuable in the transaction based on a price range of $6.00 to
$9.00 per share.

For more information about our investigation, please contact Joshua M.
Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail
including your contact information to: info@jlclasslaw.com.

Young Innovations, Inc.

Lifshitz Law Firm announces an investigation into possible breaches of
fiduciary duty in connection with the proposed sale of Young Innovations, Inc.
(Nasdaq: YDNT) (referred to as "Young") to an affiliate of Linden Capital
Partners (referred to as "Linden Capital") in a cash transaction.  Under the
terms of the agreement, holders of outstanding shares of common stock of Young
will receive $39.50 per share.

For more information about our investigation, please contact Joshua M.
Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail
including your contact information to: info@jlclasslaw.com.

Lifshitz Law Firm is a New York based law firm with significant experience
representing investors in merger-related shareholder class actions,
shareholder derivative actions, and securities fraud class actions.  For more
information about the firm, please visit our website at www.jlclasslaw.com.

ATTORNEY ADVERTISING. © 2012 Lifshitz Law Firm.  The law firm responsible for
this advertisement is Lifshitz Law Firm, 18 East 41^st Street, New York, New
York 10017, (212) 213-6222.  Prior results do not guarantee or predict a
similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law Firm
Phone:   212-213-6222
Email: info@jlclasslaw.com

SOURCE Lifshitz Law Firm

Website: http://www.jlclasslaw.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement